(Q40258094)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Retrospective cost-effectiveness analyses for polio vaccination in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

Radboud J Duintjer Tebbens

23 December 2019

series ordinal

2

object named as

Radboud J Duintjer Tebbens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

1423-1440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17184390%20AND%20SRC:MED&resulttype=core&format=json

Costs and benefits of polio eradication: a long-run global perspective

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Varicella vaccination in England and Wales: cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Varicella vaccination in Italy : an economic evaluation of different scenarios

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

An economic evaluation of universal vaccination against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

A population dynamic approach to the cost-effectiveness analysis of mass anthelmintic treatment: effects of treatment frequency on Ascaris infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Control of Ascaris infection by chemotherapy: which is the most cost-effective option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Vaccine programmes and policies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Economic evaluations of varicella vaccination programmes: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

The hidden costs of infant vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Parents' preferences for outcomes associated with childhood vaccinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Vaccine policy changes and epidemiology of poliomyelitis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Poliomyelitis vaccination campaign in Salt Lake City, Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Surveillance of poliomyelitis in the United States, 1962-65.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Ethics and immunization policy: promoting dialogue to sustain consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Learning from evidence in a complex world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Malaria eradication and control from a global standpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Resurgent malaria at the millennium: control strategies in crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Outbreaks of paralytic poliomyelitis, 1976-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Forty years and four surveys: how does our measuring measure up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X

Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1539-6924.2006.00831.X